|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest bearing deposits in banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Investment securities: | ||||||||||||||||||||
| Held-to-maturity (estimated fair values of $94.5 and $400.7 at December 31, 2019 and 2018, respectively) | ||||||||||||||||||||
| Available-for-sale, at fair value | ||||||||||||||||||||
| Held-to-maturity (estimated fair values of $2,000.3 at June 30, 2026 and $2,136.6 at December 31, 2025) | ||||||||||||||||||||
| Total investment securities | ||||||||||||||||||||
| Federal Home Loan Bank Stock and Federal Reserve Bank Stock | ||||||||||||||||||||
| Loans held for sale ($2.1 and $1.1 of which is recorded at fair value at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Loans held for investment, net of deferred fees and costs | ||||||||||||||||||||
| Loans and Leases Receivable, Collateral for Secured Borrowings | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Net loans held for investment | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Bank Owned Life Insurance | ||||||||||||||||||||
| Premises and equipment, net of accumulated depreciation | ||||||||||||||||||||
| Other intangibles, net of accumulated amortization | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Mortgage servicing rights, net of accumulated amortization | ||||||||||||||||||||
| Real Estate Acquired Through Foreclosure | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Securities sold under repurchase agreements | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Allowance for credit losses on off-balance sheet credit exposures | ||||||||||||||||||||
| Subordinated debentures held by subsidiary trusts | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred Stock, Shares Authorized | ||||||||||||||||||||
| Preferred Stock, Par or Stated Value Per Share | ||||||||||||||||||||
| Preferred Stock, Shares Issued | ||||||||||||||||||||
| Preferred Stock, Shares Outstanding | ||||||||||||||||||||
| Preferred Stock, No Par Value | ||||||||||||||||||||
| Common Stock, Shares, Issued | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.00001 par value; 100,000 shares authorized at June 30, 2026 and December 31, 2025; zero issued and outstanding, respectively | ||||||||||||||||||||
| Common stock and additional paid-in-capital, $0.00001 par value; 150,000,000 shares authorized at June 30, 2026 and December 31, 2025; 95,548,084 and 101,105,745 shares issued and outstanding, respectively | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| Common Stock, Shares Authorized | ||||||||||||||||||||
| Shares outstanding (in shares) | ||||||||||||||||||||
| Common Stock, Par or Stated Value Per Share | ||||||||||||||||||||
Loading...
